Sort   by:  
 Page size 
UnknownNeutrophil Heterogeneity Identifies an Association of LAMP1 With Proliferative Lupus Nephritis.
Not available
S-EPMC12322514 | biostudies-literature
TranscriptomicseIF3a in Urinary Bladder Cancer M-bM-^@M-^S in vivo and in vitro insights
The eukaryotic translation initiation factor (eIF) 3a is described in various tumor entities as potential tumor marker involved in development and progression of cancer. eIF3a is the largest subunit of the eIF3 complex, a key functional entity in 80S establishment and translation initiation. We hypo...
ORGANISM(S): Homo sapiens 
2014-08-12 | E-GEOD-45636 | biostudies-arrayexpress
ProteomicsAn Outer Membrane Protein-Targeting Antibiotic Against Resistant Gram-Negative Bacterial Pathogens
There is an urgent need for novel antibiotics against carbapenem and 3rd generation cephalosporin-resistant Gram-negative pathogens, for which the last-resort antibiotics have lost most of their efficacy. We describe here a novel class of synthetic antibiotics that was inspired from natural product-...
ORGANISM(S): Escherichia Coli (ncbitaxon:562) 
2020-02-04 | MSV000084899 | MassIVE
UnknownComprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome.
Not available
S-EPMC11339614 | biostudies-literature
UnknownThe ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome.
Not available
S-EPMC6752273 | biostudies-literature
UnknownTree-based classification model for Long-COVID infection prediction with age stratification using data from the National COVID Cohort Collaborative.
Not available
S-EPMC11547948 | biostudies-literature
UnknownAn interconnected data infrastructure to support large-scale rare disease research.
Not available
S-EPMC11413801 | biostudies-literature
UnknownComprehensive reanalysis for CNVs in ES data from unsolved rare disease cases results in new diagnoses.
Not available
S-EPMC11513043 | biostudies-literature
UnknownCrowd-sourced machine learning prediction of long COVID using data from the National COVID Cohort Collaborative.
Not available
S-EPMC11462169 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
Sort   by:  
 Page size